4.4 Article

Branched Fatty Acid Esters of Hydroxy Fatty Acids Are Preferred Substrates of the MODY8 Protein Carboxyl Ester Lipase

Journal

BIOCHEMISTRY
Volume 55, Issue 33, Pages 4636-4641

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acs.biochem.6b00565

Keywords

-

Funding

  1. National Institutes of Health [DA033760, DK909810]
  2. Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED002]
  3. National Cancer Institute Cancer Center Support Grant [P30 (CA014195)]
  4. Dr. Frederick Paulsen Chair/Ferring Pharmaceuticals [DK098002]
  5. JPB foundation
  6. Hewitt Foundation
  7. Chapman Charitable Trust Fellowship
  8. UCSD Medical Scientist Training Program funding [T32 GM007198]
  9. Irving S. Sigal postdoctoral fellowship from the American Chemical Society
  10. Western Norway Regional Health Authority
  11. Novo Nordisk Foundation
  12. KG Jebsen Foundation
  13. [DK106210]
  14. Novo Nordisk Fonden [NNF14OC0010659, NNF15OC0016330] Funding Source: researchfish

Ask authors/readers for more resources

A recently discovered class of endogenous mammalian lipids, branched fatty acid esters of hydroxy fatty acids (FAHFAs), possesses anti-diabetic and anti-inflammatory activities. Here, we identified and validated carboxyl ester lipase (CEL), a pancreatic enzyme hydrolyzing cholesteryl esters and other dietary lipids, as a FAHFA hydrolase. Variants of CEL have been linked to maturity-onset diabetes of the young, type 8 (MODY8), and to chronic pancreatitis. We tested the FAHFA hydrolysis activity of the CEL MODY8 variant and found a modest increase in activity as compared with that of the normal enzyme. Together, the data suggest that CEL might break down dietary FAHFAs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available